Accuracy of MRI for prediction of response to neo-adjuvant chemotherapy in triple negative breast cancer
© Bansal and Santosh 2015
Published: 2 October 2015
The aim of this study was to compare the accuracy of MRI for prediction of response to neo-adjuvant chemotherapy in triple negative breast cancer, with respect to other molecular types.
The study comprised of 82 patients who underwent MRI before and after neo-adjuvant chemotherapy but just before surgery. Triple negative cancers were analysed with respect to others subtypes in terms of presentation on MRI (mass or non –mass like enhancement), grade, axillary involvement, shrinkage pattern on MR following chemotherapy and imaging and pathological complete response rate. Accuracy of MRI for prediction of pathological complete response was also compared between different subtypes, by obtaining ROC curves. SPSS (version 21) was used for all data analysis with p value of 0.05 as statistically significant.
Out of a total of 82 patients, 29 were luminal (HR+/HER -), 23 were triple negative (HR-,HER-), 11 HER positive (HR-,HER+), 19 (HR+/HER+ hybrid). Triple negative cancers are more likely to present as masses on MRI on the pre-chemotherapy MRI scan, were grade 3 and show concentric shrinkage following chemotherapy. Triple negative cancers are more likely to have both imaging and pathological complete response following chemotherapy (p=0.055). For the triple negative group, MR had a sensitivity of 0.745 and specificity of 0.700 (p=0.035), with an area under curve (AUC) of 0.745(95% CI 0.526-0.965).
Triple negative breast cancers present as masses and show concentric shrinkage following chemotherapy. MRI is most sensitive and specific in predicting response to chemotherapy in this group, compared to others subtypes.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.